GPR55 and Parkinson disease: The expression of CB2R in the neurons of the CNS has been less well characterized, and the described changes in CB2R-GPR55 heteromer levels in the striatum of the Macaca fascicularis model of Parkinson’s disease were attributed to the upregulation of heteromers in activated microglia [30].